MANAGEMENT & TEAMS
Dr. Nadya Lisovoder
Nadya is an accomplished doctor of medicine with over fifteen years of domestic and international experience in academic and clinical studies in the pharmaceutical, diagnostic, and medical devices industry. She is a regulatory expert and has been a clinical adviser to public biotech companies and a range of incubator and accelerator programs, including FutuRx—a Johnson & Johnson Innovation and Takeda Pharmaceutical Company program.
Nadya has managed clinical trials across multiple therapy areas in complex multisite studies across Israel, Europe, and the US for large pharma companies, such as Schering-Plough, as well as innovative start-ups. Since 2012, she has been leading the Israeli government’s biomedical research in seven hospitals in northern Israel, alongside universities, international pharma companies, global contract research organizations, and biotech companies.
Prof. Itamar Shalit
Itamar earned his MD at the Sackler Faculty of Medicine at Tel Aviv University. He completed his fellowship in pediatric infectious diseases at the Children's Memorial Hospital in Oklahoma City and earned a master’s degree in public administration from the Kennedy School of Government at Harvard University.
The team is accountable for
regulatory submissions to various
ethics committees and ministries of
The monitoring team is responsible
for overseeing trials, recruitments of
patients, and any queries. They manage
and monitor each test, to ensure they
are following protocol and regulatory
Senior professionals, responsible for trial planning and statistical analysis. Highly experienced with FDA & EMA projects,
Galilee CBR has a highly trained writer that is skilled in working with the FDA and EMA.